FDA Approvals

Date Posted
Article Title
6/24/2019
6/18/2019
6/11/2019
6/11/2019
6/11/2019
6/11/2019
5/31/2019
5/28/2019
First PI3K Inhibitor Approved for Metastatic, Advanced Breast Cancer

Piqray approved for HR-positive, HER2-negative, PIK3CA-mutated, metastatic or advanced breast cancer

4/29/2019
4/29/2019
4/15/2019
4/9/2019
4/4/2019
4/1/2019
3/29/2019
3/28/2019
3/27/2019
3/21/2019
3/19/2019
3/6/2019